UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7138) 7138
Magazine Article (10) 10
Book Chapter (8) 8
Conference Proceeding (4) 4
Publication (3) 3
Book / eBook (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6716) 6716
science & technology (5259) 5259
life sciences & biomedicine (5174) 5174
female (4435) 4435
male (4360) 4360
antimetabolites, antineoplastic - adverse effects (4193) 4193
middle aged (3601) 3601
aged (3333) 3333
oncology (3045) 3045
antimetabolites, antineoplastic - therapeutic use (3028) 3028
antimetabolites, antineoplastic - administration & dosage (2938) 2938
adult (2581) 2581
biological and medical sciences (2270) 2270
medical sciences (2253) 2253
deoxycytidine - analogs & derivatives (1989) 1989
chemotherapy (1943) 1943
treatment outcome (1755) 1755
pharmacology. drug treatments (1431) 1431
fluorouracil - adverse effects (1395) 1395
antineoplastic combined chemotherapy protocols - therapeutic use (1305) 1305
antineoplastic agents (1295) 1295
deoxycytidine - adverse effects (1292) 1292
cancer (1260) 1260
fluorouracil - administration & dosage (1140) 1140
aged, 80 and over (1089) 1089
pharmacology & pharmacy (1061) 1061
antineoplastic combined chemotherapy protocols - adverse effects (988) 988
deoxycytidine - therapeutic use (982) 982
deoxycytidine - administration & dosage (937) 937
fluorouracil - therapeutic use (916) 916
tumors (868) 868
drug administration schedule (849) 849
capecitabine (805) 805
animals (742) 742
gemcitabine (736) 736
medicine & public health (729) 729
methotrexate - adverse effects (712) 712
hematology (705) 705
care and treatment (697) 697
fluorouracil - analogs & derivatives (674) 674
retrospective studies (672) 672
survival analysis (602) 602
adolescent (597) 597
disease-free survival (585) 585
adenocarcinoma - drug therapy (572) 572
survival rate (547) 547
colorectal neoplasms - drug therapy (543) 543
pancreatic neoplasms - drug therapy (543) 543
dose-response relationship, drug (536) 536
5-fluorouracil (531) 531
antimetabolites, antineoplastic - pharmacology (531) 531
drug combinations (531) 531
neoplasm staging (529) 529
methotrexate (526) 526
combined modality therapy (523) 523
child (511) 511
methotrexate - administration & dosage (506) 506
antimetabolites, antineoplastic - pharmacokinetics (487) 487
research (479) 479
infusions, intravenous (473) 473
prognosis (455) 455
abridged index medicus (445) 445
breast neoplasms - drug therapy (428) 428
neoplasms - drug therapy (427) 427
toxicity (421) 421
analysis (413) 413
fluorouracil (413) 413
lung neoplasms - drug therapy (410) 410
time factors (408) 408
prospective studies (405) 405
follow-up studies (402) 402
risk factors (402) 402
chemotherapy, adjuvant (401) 401
administration, oral (398) 398
gastroenterology. liver. pancreas. abdomen (392) 392
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (389) 389
colorectal cancer (384) 384
drug therapy (384) 384
antineoplastic combined chemotherapy protocols - administration & dosage (379) 379
surgery (377) 377
antimitotic agents (374) 374
pancreatic cancer (368) 368
antineoplastic agents - adverse effects (358) 358
child, preschool (357) 357
stomach neoplasms - drug therapy (343) 343
remission induction (340) 340
disease progression (338) 338
pharmacology/toxicology (336) 336
health aspects (335) 335
tegafur - administration & dosage (334) 334
hematology, oncology and palliative medicine (326) 326
tegafur - adverse effects (319) 319
cisplatin - administration & dosage (315) 315
leucovorin - administration & dosage (307) 307
antineoplastic agents - administration & dosage (306) 306
methotrexate - therapeutic use (305) 305
dosage and administration (303) 303
tegafur - therapeutic use (301) 301
drug toxicity and drugs side effects treatment (300) 300
radiotherapy (297) 297
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6603) 6603
Japanese (351) 351
French (125) 125
German (89) 89
Chinese (56) 56
Spanish (53) 53
Russian (37) 37
Italian (21) 21
Dutch (13) 13
Polish (9) 9
Danish (8) 8
Hungarian (8) 8
Portuguese (8) 8
Finnish (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Korean (2) 2
Lithuanian (2) 2
Turkish (2) 2
Czech (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2012, Volume 23, Issue 11, pp. 2799 - 2805
phase III randomized trial | gemcitabine | sorafenib | advanced pancreatic cancer | Advanced pancreatic cancer | Gemcitabine | Sorafenib | Phase III randomized trial | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Niacinamide - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Placebos | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Deoxycytidine - administration & dosage | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Niacinamide - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Phenylurea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Ribonucleotide Reductases - antagonists & inhibitors | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 12/2016, Volume 122, Issue 24, pp. 3803 - 3811
clinical trial | duligotuzumab | human epidermal growth factor receptor 3 (HER3) | antibody | epidermal growth factor receptor (EGFR) | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Antineoplastic Agents - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | Carboplatin - adverse effects | Antineoplastic Agents, Phytogenic - administration & dosage | Squamous Cell Carcinoma of Head and Neck | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - adverse effects | Head and Neck Neoplasms - drug therapy | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Immunoglobulin G - administration & dosage | Immunoglobulin G - adverse effects | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Cisplatin - adverse effects | Aged | Squamous cell carcinoma | Care and treatment | Usage | Head and neck cancer | Research | Diagnosis | Cisplatin | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 215 - 221
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2895 - 2902
Journal Article
Annals of oncology, ISSN 0923-7534, 03/2014, Volume 25, Issue 3, pp. 638 - 643
paclitaxel | esophageal | cancer | definitive | chemoradiation | carboplatin | SURVIVAL | FOLLOW-UP | CHEMORADIOTHERAPY | NETHERLANDS | CARCINOMA | CHEMOTHERAPY | Carboplatin | Definitive | Esophageal | Chemoradiation | Paclitaxel | Cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Esophagus | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Esophageal Neoplasms - radiotherapy | Chemoradiotherapy | Carboplatin - adverse effects | Fluorouracil - therapeutic use | Carboplatin - therapeutic use | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Esophageal Neoplasms - mortality | Female | Retrospective Studies | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Tubulin Modulators - adverse effects | Paclitaxel - adverse effects | Treatment Outcome | Paclitaxel - therapeutic use | Tubulin Modulators - therapeutic use | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Cisplatin - adverse effects | Esophageal Neoplasms - drug therapy | Index Medicus | Original
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Journal Article
Blood, ISSN 0006-4971, 06/2017, Volume 129, Issue 25, pp. 3304 - 3313